Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gregory A. Horwitz is active.

Publication


Featured researches published by Gregory A. Horwitz.


Nature Medicine | 1999

Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis

Anthony P. Heaney; Gregory A. Horwitz; Zhiyong Wang; Regina Singson; Shlomo Melmed

Pituitary tumors are commonly encountered, and result from clonal expansion of a single mutated cell. Hypothalamic hormones, local growth factors and circulating sex steroid hormones promote pituitary tumor growth and expansion into large invasive tumors. Estrogen acting directly through its receptor and by stimulation of fibroblast growth factor regulates prolactin synthesis and secretion. Fibroblast growth factor-2 (bFGF) modulates angiogenesis, tumor formation and progression in many tissues, including the anterior pituitary. A pituitary tumor-derived transforming gene (PTTG) has been isolated, which is tumorigenic in vivo, regulates bFGF secretion, and inhibits chromatid separation. The human PTTG family consists of at least three homologous genes, of which PTTG1 is located on chromosome 5q33 and is expressed at low levels in most normal human tissues but is highly expressed in malignant human cell lines and in pituitary tumors. We report here that pituitary pttg is regulated in vivo and in vitro by estrogen. Maximal induction of rat pituitary pttg mRNA in vivo occurred early in pituitary transformation (normal cell to hypertrophic/hyperplastic cell), coincident with bFGF and vascular endothelial growth factor induction and pituitary angiogenesis. We also demonstrate that pttg expression is induced by bFGF, and show concordant pttg and bFGF expression in experimental and human pituitary adenomas. As bFGF and estrogen both induce pttg, and pttg expression coincides with the early lactotrophic hyperplastic response, angiogenesis and prolactinoma development, we propose a previously unknown paracrine growth factor-mediated mechanism for pituitary tumor pathogenesis and potentially other estrogen-regulated tumors.


Proceedings of the National Academy of Sciences of the United States of America | 2009

Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells

Pierre-Olivier Estève; Hang Gyeong Chin; Jack S. Benner; George R. Feehery; Mala Samaranayake; Gregory A. Horwitz; Steven E. Jacobsen; Sriharsa Pradhan

Inheritance of epigenetic information encoded by cytosine DNA methylation patterns is crucial for mammalian cell survival, in large part through the activity of the maintenance DNA methyltransferase (DNMT1). Here, we show that SET7, a known histone methyltransferase, is involved in the regulation of protein stability of DNMT1. SET7 colocalizes and directly interacts with DNMT1 and specifically monomethylates Lys-142 of DNMT1. Methylated DNMT1 peaks during the S and G2 phases of the cell cycle and is prone to proteasome-mediated degradation. Overexpression of SET7 leads to decreased DNMT1 levels, and siRNA-mediated knockdown of SET7 stabilizes DNMT1. These results demonstrate that signaling through SET7 represents a means of DNMT1 enzyme turnover.


Science | 2008

Epigenetic Reprogramming by Adenovirus e1a

Roberto Ferrari; Matteo Pellegrini; Gregory A. Horwitz; Wei Xie; Arnold J. Berk; Siavash K. Kurdistani

Adenovirus e1a induces quiescent human cells to replicate. We found that e1a causes global relocalization of the RB (retinoblastoma) proteins (RB, p130, and p107) and p300/CBP histone acetyltransferases on promoters, the effect of which is to restrict the acetylation of histone 3 lysine-18 (H3K18ac) to a limited set of genes, thereby stimulating cell cycling and inhibiting antiviral responses and cellular differentiation. Soon after expression, e1a binds transiently to promoters of cell cycle and growth genes, causing enrichment of p300/CBP, PCAF (p300/CBP-associated factor), and H3K18ac; depletion of RB proteins; and transcriptional activation. e1a also associates transiently with promoters of antiviral genes, causing enrichment for RB, p130, and H4K16ac; increased nucleosome density; and transcriptional repression. At later times, e1a and p107 bind mainly to promoters of development and differentiation genes, repressing transcription. The temporal order of e1a binding requires its interactions with p300/CBP and RB proteins. Our data uncover a defined epigenetic reprogramming leading to cellular transformation.


Science | 2008

Adenovirus Small e1a Alters Global Patterns of Histone Modification

Gregory A. Horwitz; Kangling Zhang; Matthew A. McBrian; Michael Grunstein; Siavash K. Kurdistani; Arnold J. Berk

Adenovirus small early region 1a (e1a) protein drives cells into S phase by binding RB family proteins and the closely related histone acetyl transferases p300 and CBP. The interaction with RB proteins displaces them from DNA-bound E2F transcription factors, reversing their repression of cell cycle genes. However, it has been unclear how the e1a interaction with p300 and CBP promotes passage through the cell cycle. We show that this interaction causes a threefold reduction in total cellular histone H3 lysine 18 acetylation (H3K18ac). CBP and p300 are required for acetylation at this site because their knockdown causes specific hypoacetylation at H3K18. SV40 T antigen also induces H3K18 hypoacetylation. Because global hypoacetylation at this site is observed in prostate carcinomas with poor prognosis, this suggests that processes resulting in global H3K18 hypoacetylation may be linked to oncogenic transformation.


PLOS Genetics | 2010

The De Novo Cytosine Methyltransferase DRM2 Requires Intact UBA Domains and a Catalytically Mutated Paralog DRM3 during RNA-Directed DNA Methylation in Arabidopsis thaliana

Ian R. Henderson; Angelique Deleris; William Wong; Xuehua Zhong; Hang Gyeong Chin; Gregory A. Horwitz; Krystyna A. Kelly; Sriharsa Pradhan; Steven E. Jacobsen

Eukaryotic DNA cytosine methylation can be used to transcriptionally silence repetitive sequences, including transposons and retroviruses. This silencing is stable between cell generations as cytosine methylation is maintained epigenetically through DNA replication. The Arabidopsis thaliana Dnmt3 cytosine methyltransferase ortholog DOMAINS REARRANGED METHYLTRANSFERASE2 (DRM2) is required for establishment of small interfering RNA (siRNA) directed DNA methylation. In mammals PIWI proteins and piRNA act in a convergently evolved RNA–directed DNA methylation system that is required to repress transposon expression in the germ line. De novo methylation may also be independent of RNA interference and small RNAs, as in Neurospora crassa. Here we identify a clade of catalytically mutated DRM2 paralogs in flowering plant genomes, which in A.thaliana we term DOMAINS REARRANGED METHYLTRANSFERASE3 (DRM3). Despite being catalytically mutated, DRM3 is required for normal maintenance of non-CG DNA methylation, establishment of RNA–directed DNA methylation triggered by repeat sequences and accumulation of repeat-associated small RNAs. Although the mammalian catalytically inactive Dnmt3L paralogs act in an analogous manner, phylogenetic analysis indicates that the DRM and Dnmt3 protein families diverged independently in plants and animals. We also show by site-directed mutagenesis that both the DRM2 N-terminal UBA domains and C-terminal methyltransferase domain are required for normal RNA–directed DNA methylation, supporting an essential targeting function for the UBA domains. These results suggest that plant and mammalian RNA–directed DNA methylation systems consist of a combination of ancestral and convergent features.


The Journal of Clinical Endocrinology and Metabolism | 1999

Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas

Xun Zhang; Gregory A. Horwitz; Anthony P. Heaney; Masahiro Nakashima; Toni R. Prezant; Marcello D. Bronstein; Shlomo Melmed


Molecular Endocrinology | 1999

Structure, Expression, and Function of Human Pituitary Tumor- Transforming Gene (PTTG)

Xun Zhang; Gregory A. Horwitz; Toni R. Prezant; Alberto Valentini; Masahiro Nakashima; Marcello D. Bronstein; Shlomo Melmed


The Journal of Clinical Endocrinology and Metabolism | 2001

Human pituitary tumor-transforming gene induces angiogenesis

Hiroki Ishikawa; Anthony P. Heaney; Run Yu; Gregory A. Horwitz; Shlomo Melmed


Molecular Endocrinology | 2000

Pituitary Tumor Transforming Gene (PTTG) Regulates Placental JEG-3 Cell Division and Survival: Evidence from Live Cell Imaging

Run Yu; Song-Guang Ren; Gregory A. Horwitz; Zhiyong Wang; Shlomo Melmed


The Journal of Clinical Endocrinology and Metabolism | 2001

Transforming Events in Thyroid Tumorigenesis and Their Association with Follicular Lesions

Anthony P. Heaney; Viera Nelson; Manory Fernando; Gregory A. Horwitz

Collaboration


Dive into the Gregory A. Horwitz's collaboration.

Top Co-Authors

Avatar

Shlomo Melmed

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Xun Zhang

University of California

View shared research outputs
Top Co-Authors

Avatar

Anthony P. Heaney

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Run Yu

University of California

View shared research outputs
Top Co-Authors

Avatar

Arnold J. Berk

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Song-Guang Ren

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge